Page 9 - வெளிப்படுகிறது தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(AUSTIN, Texas) NEWS: Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Northwestern University, a world leader in HLA DQ antigen research. The focus of the collaboration is to develop and test novel HLA reagents created by PTS that may be used for enhanced analysis and characterization of DQ antigens, an HLA Class II type that is increasingly gaining importance in causing rejection in transplant patients. The research is being led by Dr. Anat Tambur, Director of the Transplant Immunology Laboratory and Comprehensive Transplant Center at Northwestern University Feinberg School of Medicine, and Dr. Rico Buchli, VP of Products and Services at PTS.

Northwestern universityUnited statesEmergent technologies incUniversity of oklahomaPure proteinPure transplant solutionsImmunology laboratoryAnat tamburTransplant immunology laboratoryComprehensive transplant centerNorthwestern university feinberg schoolRico buchliTransplant solutionsEmergent technologiesவடமேற்கு பல்கலைக்கழகம்ஒன்றுபட்டது மாநிலங்களில்